Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01420458 · ClinicalTrials.gov registry record · Phase 1
Study in Healthy Volunteers to Establish the BioEquivalence of Two Formulations of BG00012
A Phase 1 study, sponsored by Biogen.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT01420458 is a Phase 1 study that has completed, run by Biogen. The registered enrollment target is 80 participants.
The verdict
NCT01420458, a Phase 1 study, has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
This is an open-label, single-center, 2 period crossover, PK profile study. Each subject will be randomized to 1 of 2 treatment sequences. Both treatment sequences will be enrolled concurrently.
Interventions
- DRUG Experimental
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2011-08 |
| Est. Completion | 2011-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01420458
The ClinicalTrials.gov registry entry for NCT01420458 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Experimental is the first listed.
NCT01420458 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01420458 about?
NCT01420458 is a clinical study titled "Study in Healthy Volunteers to Establish the BioEquivalence of Two Formulations of BG00012". This is an open-label, single-center, 2 period crossover, PK profile study. Each subject will be randomized to 1 of 2 treatment sequences. Both treatment sequences will be enrolled concurrently.
What is the current status of trial NCT01420458?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2011-08. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01420458?
The interventions under investigation include: Experimental (DRUG).
Who is sponsoring clinical trial NCT01420458?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.